Wellness practitioners and clinics looking to incorporate non-invasive vagus nerve stimulation into their client programs can now work with Nuropod, by Parasym, through the firm's professional partnership program.
-- With more clients seeking support around stress, recovery, and nervous-system health, Nuropod, created by Parasym, is partnering with wellness practitioners and clinics that want to incorporate non-invasive vagus nerve stimulation into their existing programs. The professional network gives practitioners access to AVNT™ education, recommended protocols, scientific resources, and opportunities to introduce the wearable technology within an established wellness setting.
More information is available at https://nuropod.com/pages/for-professionals
The announcement comes as persistent stress increasingly shapes everyday life for U.S. adults. The American Psychological Association’s 2026 Stress in America survey found that 72% of adults agreed that stress is simply something they have to live with, reinforcing the demand wellness professionals are seeing for practical ways to support rest, recovery, and nervous-system health.
As the firm explains, the vagus nerve carries signals between the brain and organs including the heart, lungs, and gut, and plays an important role in how the body handles stress, rest, and recovery. Specifically, Nuropod uses an earpiece positioned at the tragus to deliver gentle electrical pulses through Parasym’s proprietary AVNT™ waveform, with stimulation designed to support that system.
For practitioners, the program is designed to make that integration more practical. Participants can become AVNT™ practitioners through CPD-accredited education, access recommended protocols and scientific resources, and receive implementation guidance from Parasym, giving them a supporting framework for introducing the technology into their practice.
The wearable format also allows the client experience to extend beyond an appointment. Nuropod is designed for ordinary daily use, with most people using the device for around 30 minutes once or twice a day while working, reading, or watching television, allowing practitioners to incorporate in-practice guidance alongside at-home continuation where appropriate.
Parasym says its technology is supported by more than 60 completed clinical studies and more than 100 ongoing studies, with its professional network also including more than 1,000 healthcare professionals. Participating practitioners can access the company's scientific research team and opportunities to trial Nuropod with users.
About Nuropod
Nuropod is a wearable neurotechnology product developed by Parasym Scientific around its proprietary AVNT™ waveform. The consumer wellness device is designed for non-invasive vagus nerve stimulation through the tragus and is supported by research conducted using Parasym’s technology.
More information can be found at https://nuropod.com/pages/for-professionals
Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-designated risk device and is not intended to diagnose, treat, cure, or prevent any disease.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/
Source: PressCable
Release ID: 89208976
In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.
